Integra LifeSciences
IART
IART
251 hedge funds and large institutions have $4.8B invested in Integra LifeSciences in 2020 Q4 according to their latest regulatory filings, with 31 funds opening new positions, 83 increasing their positions, 92 reducing their positions, and 15 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
more ownership
Funds ownership: →
10% less repeat investments, than reductions
Existing positions increased: 83 | Existing positions reduced: 92
25% less funds holding in top 10
Funds holding in top 10: 4 → 3 (-1)
37% less call options, than puts
Call options by funds: $2.61M | Put options by funds: $4.13M
Holders
251
Holding in Top 10
3
Calls
$2.61M
Puts
$4.13M
Top Buyers
| 1 | +$93.6M | |
| 2 | +$51.5M | |
| 3 | +$37.2M | |
| 4 |
CB
Cooke & Bieler
Philadelphia,
Pennsylvania
|
+$15.9M |
| 5 |
Fuller & Thaler Asset Management
San Mateo,
California
|
+$13.4M |
Top Sellers
| 1 | -$46.9M | |
| 2 | -$29.5M | |
| 3 | -$19M | |
| 4 |
ECM
Endurant Capital Management
San Mateo,
California
|
-$13.3M |
| 5 |
Goldman Sachs
New York
|
-$12.4M |